| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239475 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 4 Pages |
Abstract
Intravitreal bevacizumab can be used to treat radiation retinopathy. In most cases treatment was associated with decreased vascular leakage, stabilization, or improved vision. An anti-vascular endothelial growth factor strategy may reduce tissue damage associated with radiation vasculopathy and neuropathy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paul T. M.D.,